NCT01728948View on ClinicalTrials.gov

Sorafenib in Elderly mRCC

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

January 6, 2013

Primary Completion Date

January 4, 2016

Study Completion Date

January 16, 2017

Conditions
Carcinoma, Renal Cell
Interventions
DRUG

Sorafenib (Nexavar, BAY43-9006)

treatment (including dose, duration, modification) decided by the investigator

Trial Locations (1)

Unknown

Many Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT01728948 - Sorafenib in Elderly mRCC | Biotech Hunter | Biotech Hunter